- FSD Pharma ( NASDAQ: HUGE ) received Nasdaq notification stating the company is not in compliance with the minimum bid price requirement.
- The company’s class B subordinate voting shares has not maintained a minimum bid price of $1.00/share for the 30 consecutive business days from August 15, 2022 to September 26, 2022.
- The company has been provided 180 calendar days, or until March 27, 2023, to regain compliance.
- If the company does not regain compliance by March 27, 2023, the company may be eligible for additional time to regain compliance or may face delisting from Nasdaq.
For further details see:
FSD Pharma receives Nasdaq minimum bid price deficiency notification